Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

Andreas Hochhaus; Richard A. Larson; Francois Guilhot; Jerald P. Radich; Susan Branford; Timothy P. Hughes; Michele Baccarani; Michael W. Deininger; Francisco Cervantes; Satoko Fujihara; Christine-Elke Ortmann; Hans D. Menssen; Hagop Kantarjian; Stephen G. O'Brien; Brian J. Druker; IRIS Investigators

doi:10.1056/NEJMoa1609324

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

Andreas Hochhaus
, Richard A. Larson
, Francois Guilhot
, Jerald P. Radich
, Susan Branford
, Timothy P. Hughes
, Michele Baccarani
, Michael W. Deininger
, Francisco Cervantes
, Satoko Fujihara
, Christine-Elke Ortmann
, Hans D. Menssen
, Hagop Kantarjian
, Stephen G. O'Brien
, Brian J. Druker
, IRIS Investigators

Research output: Contribution to journal › Article › Academic › peer-review

90 Downloads (Pure)

Original language	English
Pages (from-to)	917-927
Journal	New England journal of medicine
Volume	376
Issue number	10
DOIs	https://doi.org/10.1056/NEJMoa1609324
Publication status	Published - 9 Mar 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1056/NEJMoa1609324

Long-term-outcomes-of-imatinib-treatment-for-chronic-myeloid-leukemia.pdfFinal published version, 345 KBLicence: Taverne

Cite this

Hochhaus, A., Larson, R. A., Guilhot, F., Radich, J. P., Branford, S., Hughes, T. P., Baccarani, M., Deininger, M. W., Cervantes, F., Fujihara, S., Ortmann, C.-E., Menssen, H. D., Kantarjian, H., O'Brien, S. G., Druker, B. J., & IRIS Investigators (2017). Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia. New England journal of medicine, 376(10), 917-927. https://doi.org/10.1056/NEJMoa1609324

@article{e23e48ecc94c4b7097041a05e4319f93,

title = "Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia",

author = "Andreas Hochhaus and Larson, \{Richard A.\} and Francois Guilhot and Radich, \{Jerald P.\} and Susan Branford and Hughes, \{Timothy P.\} and Michele Baccarani and Deininger, \{Michael W.\} and Francisco Cervantes and Satoko Fujihara and Christine-Elke Ortmann and Menssen, \{Hans D.\} and Hagop Kantarjian and O'Brien, \{Stephen G.\} and Druker, \{Brian J.\} and \{IRIS Investigators\} and GJ Ossenkoppele",

year = "2017",

month = mar,

day = "9",

doi = "10.1056/NEJMoa1609324",

language = "English",

volume = "376",

pages = "917--927",

journal = "New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "10",

}

Hochhaus, A, Larson, RA, Guilhot, F, Radich, JP, Branford, S, Hughes, TP, Baccarani, M, Deininger, MW, Cervantes, F, Fujihara, S, Ortmann, C-E, Menssen, HD, Kantarjian, H, O'Brien, SG, Druker, BJ & IRIS Investigators 2017, 'Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia', New England journal of medicine, vol. 376, no. 10, pp. 917-927. https://doi.org/10.1056/NEJMoa1609324

TY - JOUR

T1 - Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

AU - Hochhaus, Andreas

AU - Larson, Richard A.

AU - Guilhot, Francois

AU - Radich, Jerald P.

AU - Branford, Susan

AU - Hughes, Timothy P.

AU - Baccarani, Michele

AU - Deininger, Michael W.

AU - Cervantes, Francisco

AU - Fujihara, Satoko

AU - Ortmann, Christine-Elke

AU - Menssen, Hans D.

AU - Kantarjian, Hagop

AU - O'Brien, Stephen G.

AU - Druker, Brian J.

AU - IRIS Investigators

AU - Ossenkoppele, GJ

PY - 2017/3/9

Y1 - 2017/3/9

U2 - 10.1056/NEJMoa1609324

DO - 10.1056/NEJMoa1609324

M3 - Article

C2 - 28273028

SN - 0028-4793

VL - 376

SP - 917

EP - 927

JO - New England journal of medicine

JF - New England journal of medicine

IS - 10

ER -